Status:
RECRUITING
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
Lead Sponsor:
Yale University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Congenital Uterine Anomaly
Eligibility:
FEMALE
13+ years
Brief Summary
The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. T...
Detailed Description
Aim 1: To identify female subjects diagnosed with a Congenital Uterine Anomaly (CUA) receiving care at Yale New Haven Health. Aim 2: Identify (i) the prevalence of renal, breast, ovarian, uterine and...
Eligibility Criteria
Inclusion
- females
- age: 13 or older
- encounters limited to: Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital and Lawrence+ Memorial Hospital.
- diagnosis of any variation of CUA
Exclusion
- who will decline to participate in a study upon contact
- non-English speaking except Spanish speaking
- unable to participate in consent or assent process due to mental disability
Key Trial Info
Start Date :
July 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04661072
Start Date
July 14 2021
End Date
August 1 2027
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06511